Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

Article  PubMed  Google Scholar 

Mottet N, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2021;79:243–62.

Article  CAS  PubMed  Google Scholar 

de V II, Meertens A, Hogenhout R, Remmers S, Roobol MJ, Group ERS. A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer. Eur Urol. 2023;84:426–34.

Article  Google Scholar 

Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, et al. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer. Eur Urol. 2019;76:43–51.

Article  PubMed  PubMed Central  Google Scholar 

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320–8.

Article  PubMed  Google Scholar 

Davik P, Remmers S, Elschot M, Roobol MJ, Bathen TF, Bertilsson H. Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratification. BJUI Compass. 2022;3:344–53.

Article  PubMed  PubMed Central  Google Scholar 

Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98:691–8.

Article  PubMed  Google Scholar 

Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW, Topic Group. ‘Evaluating diagnostic t, et al. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17:230.

Article  PubMed  PubMed Central  Google Scholar 

Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW. A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol. 2016;74:167–76.

Article  PubMed  Google Scholar 

Van Calster B, Vickers AJ. Calibration of risk prediction models: impact on decision-analytic performance. Med Decis Mak. 2015;35:162–9.

Article  Google Scholar 

Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, et al. Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators. Eur Urol. 2018;74:796–804.

Article  PubMed  PubMed Central  Google Scholar 

Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Mak. 2006;26:565–74.

Article  Google Scholar 

The Directorate General for Internal Market I, Entrepreneurship and SMEs and is an official website of the European Union. CE marking: European Union; 2024. Available from: https://europa.eu/youreurope/business/product-requirements/labels-markings/ce-marking/index_nl.htm.

Stojadinovic M, Trifunovic T, Jankovic S. Adaptation of the prostate biopsy collaborative group risk calculator in patients with PSA less than 10 ng/ml improves its performance. Int Urol Nephrol. 2020;52:1811–9.

Article  PubMed  Google Scholar 

Stojadinovic M, Milicevic B, Jankovic S. Improved predictive performance of prostate biopsy collaborative group risk calculator when based on automated machine learning. Comput Biol Med. 2021;138:104903.

Article  PubMed  Google Scholar 

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, et al. A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts. Eur Urol. 2018;74:197–203.

Article  PubMed  PubMed Central  Google Scholar 

Carbunaru S, Nettey OS, Gogana P, Helenowski IB, Jovanovic B, Ruden M, et al. A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort. BMC Urol. 2019;19:121.

Article  PubMed  PubMed Central  Google Scholar 

Chandra Engel J, Palsdottir T, Ankerst D, Remmers S, Mortezavi A, Chellappa V, et al. External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort. Eur Urol Open Sci. 2022;41:1–7.

Article  PubMed  PubMed Central  Google Scholar 

Doan P, Graham P, Lahoud J, Remmers S, Roobol MJ, Kim L, et al. A comparison of prostate cancer prediction models in men undergoing both magnetic resonance imaging and transperineal biopsy: Are the models still relevant? BJU Int. 2021;128:36–44.

Article  CAS  PubMed  Google Scholar 

Falagario UG, Silecchia G, Bruno SM, Di Nauta M, Auciello M, Sanguedolce F, et al. Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naive Patients? Front oncol. 2020;10:603384.

Article  PubMed  Google Scholar 

Amaya-Fragoso E, Garcia-Perez CM. Improving prostate biopsy decision making in Mexican patients: Still a major public health concern. Urol Oncol. 2021;39:831.e11–.e18.

Article  PubMed  Google Scholar 

Mortezavi A, Palsdottir T, Eklund M, Chellappa V, Murugan SK, Saba K, et al. Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators. Eur Urol Focus. 2021;7:546–53.

Article  PubMed  Google Scholar 

Jalali A, Foley RW, Maweni RM, Murphy K, Lundon DJ, Lynch T, et al. A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort. BMC Med Inf Decis Mak. 2020;20:148.

Article  Google Scholar 

Rubio-Briones J, Borque-Fernando A, Esteban LM, Mascaros JM, Ramirez-Backhaus M, Casanova J, et al. Validation of a 2-gene mRNA urine test for the detection of >=GG2 prostate cancer in an opportunistic screening population. Prostate. 2020;80:500–7.

Article  CAS  PubMed  Google Scholar 

Saba K, Wettstein MS, Lieger L, Hotker AM, Donati OF, Moch H, et al. External Validation and Comparison of Prostate Cancer Risk Calculators Incorporating Multiparametric Magnetic Resonance Imaging for Prediction of Clinically Significant Prostate Cancer. J Urol. 2020;203:719–26.

Article  PubMed  Google Scholar 

Wei G, Kelly BD, Timm B, Perera M, Lundon DJ, Jack G, et al. Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy. BJUI Compass. 2021;2:194–201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yildizhan M, Balci M, Eroglu U, Asil E, Coser S, Ozercan AY, et al. An analysis of three different prostate cancer risk calculators applied prior to prostate biopsy: A Turkish cohort validation study. Andrologia. 2022;54:e14329.

Article  PubMed  Google Scholar 

Engel JC, Palsdottir T, Ankerst D, Remmers S, Mortezavi A, Chellappa V, et al. External Validation of the prostate biopsy Collaborative group risk calculator and the Rotterdam prostate cancer risk calculator in a Swedish population-based screening cohort. Eur Urol Open Sci. 2022;41:1–7.

Patel HD, Koehne EL, Shea SM, Fang A, Gerena M, Gorbonos A, et al. A prostate biopsy risk calculator based on magnetic resonance imaging: Development, validation, and comparison to the PBCG risk calculator. J Urol. 2021;206:e781.

Article  Google Scholar 

Alberts AR, Roobol MJ, Verbeek JFM, Schoots IG, Chiu PK, Osses DF, et al. Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators. Eur Urol. 2019;75:310–8.

Article  PubMed  Google Scholar 

Lee HJ, Lee A, Yang XY, Law YM, Huang HH, Lau WK, et al. External validation and comparison of magnetic resonance imaging-based predictive models for clinically significant prostate cancer. Urol Oncol. 2021;39:783.e1–.e10.

Article  PubMed  Google Scholar 

Morote J, Borque-Fernando A, Triquell M, Campistol M, Servian P, Abascal JM, et al. Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer. Eur Urol Open Sci. 2023;53:46–54.

Article  PubMed  PubMed Central  Google Scholar 

Petersmann AL, Remmers S, Klein T, Manava P, Huettenbrink C, Pahernik SA, et al. External validation of two MRI-based risk calculators in prostate cancer diagnosis. World J Urol. 2021;39:4109–16.

Article  PubMed  Google Scholar 

Pullen L, Radtke JP, Wiesenfarth M, Roobol MJ, Verbeek JFM, Wetter A, et al. External validation of novel magnetic resonance imaging-based models for prostate cancer prediction. BJU Int. 2020;125:407–16.

Article  PubMed